ResearchMoz added Latest Research Report titled " Global Migraine Market Report: 2016 Edition " to it's Large Report database.
Migraine is a common neurovascular disorder that is characterized by throbbing headaches and is commonly associated with other neurological symptoms, such as nausea, vomiting, and painful sensitivity to lights and sounds. Migraines are thought to result from the activation and sensitization of sensory neurons that have nerve endings in meningeal blood vessels. Migraines can be episodic or chronic. Chronic Migraine (CM) and Episodic Migraine (EM) are both part of the spectrum of migraine disorders, but are distinct clinical entities. The onset of migraine is preceded by certain triggers, which can be unique for each migraine sufferer.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=720347
Triptans and Ergots are among the most common drug options existing in the treatment market for migraine. The global migraine treatment market currently faces several unmet needs and is saturated with the availability of generic drugs. Several branded drugs are under development with safer and more effective profiles, given the vast opportunities existing in the market. The focus of upcoming drugs is to either cure migraine or to reduce the frequency to a level where patients can find tolerable relief.
The migraine market is expected to acquire modest growth driven by launch of new therapies and increasing rate of drug treatment due to increasing female population and rising awareness among physicians and patients. The major growth drivers of the migraine market includes rising spending on medicines, growing female population, increasing cigarette consumption and healthcare expenditure. However, the growth of the market will also remain challenged by complications associated with Triptans, treatment limitations for patients with CV (Cardio Vascular) risk and increased preference for OTC (Over the Counter) medications.
Read All healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html
Table of Content
1. Market Overview
1.1 Introduction
1.2 Types
1.3 Causes and Pathogenesis
1.4 Symptoms and Diagnosis
1.5 Treatment Options
2. Global Migraine Market
2.1 Global Migraine Drug Market by Value
2.2 Global Migraine Drug Market by Category
2.3 Global Therapeutic Botulinum Toxin Market by Value
2.4 Global Therapeutic Botulinum Toxin Market by Indication
3. The U.S. Migraine Market
3.1 The U.S. Total Migraine Population
3.2 The U.S. Migraine Population by Diagnosis
3.3 The U.S. Migraine Population with CV Risk Factors
3.4 The U.S Preventive Migraine Treatment by Specialty
3.5 The U.S. Acute Migraine Treated Population by Drug Type
3.6 The U.S. Acute Migraine Prescription Volume
3.7 The U.S. Migraine Drugs Revenue
3.7.1 Cambia
3.7.2 Lasmiditan
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
Migraine is a common neurovascular disorder that is characterized by throbbing headaches and is commonly associated with other neurological symptoms, such as nausea, vomiting, and painful sensitivity to lights and sounds. Migraines are thought to result from the activation and sensitization of sensory neurons that have nerve endings in meningeal blood vessels. Migraines can be episodic or chronic. Chronic Migraine (CM) and Episodic Migraine (EM) are both part of the spectrum of migraine disorders, but are distinct clinical entities. The onset of migraine is preceded by certain triggers, which can be unique for each migraine sufferer.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=720347
Triptans and Ergots are among the most common drug options existing in the treatment market for migraine. The global migraine treatment market currently faces several unmet needs and is saturated with the availability of generic drugs. Several branded drugs are under development with safer and more effective profiles, given the vast opportunities existing in the market. The focus of upcoming drugs is to either cure migraine or to reduce the frequency to a level where patients can find tolerable relief.
The migraine market is expected to acquire modest growth driven by launch of new therapies and increasing rate of drug treatment due to increasing female population and rising awareness among physicians and patients. The major growth drivers of the migraine market includes rising spending on medicines, growing female population, increasing cigarette consumption and healthcare expenditure. However, the growth of the market will also remain challenged by complications associated with Triptans, treatment limitations for patients with CV (Cardio Vascular) risk and increased preference for OTC (Over the Counter) medications.
Read All healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html
Table of Content
1. Market Overview
1.1 Introduction
1.2 Types
1.3 Causes and Pathogenesis
1.4 Symptoms and Diagnosis
1.5 Treatment Options
2. Global Migraine Market
2.1 Global Migraine Drug Market by Value
2.2 Global Migraine Drug Market by Category
2.3 Global Therapeutic Botulinum Toxin Market by Value
2.4 Global Therapeutic Botulinum Toxin Market by Indication
3. The U.S. Migraine Market
3.1 The U.S. Total Migraine Population
3.2 The U.S. Migraine Population by Diagnosis
3.3 The U.S. Migraine Population with CV Risk Factors
3.4 The U.S Preventive Migraine Treatment by Specialty
3.5 The U.S. Acute Migraine Treated Population by Drug Type
3.6 The U.S. Acute Migraine Prescription Volume
3.7 The U.S. Migraine Drugs Revenue
3.7.1 Cambia
3.7.2 Lasmiditan
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
No comments:
Post a Comment